BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36152104)

  • 1. Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients.
    Szymczak M; Heidecke H; Żabińska M; Rukasz D; Wiśnicki K; Tukiendorf A; Krajewska M; Banasik M
    Arch Immunol Ther Exp (Warsz); 2022 Sep; 70(1):23. PubMed ID: 36152104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
    Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
    BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
    Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
    Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
    [No Abstract]   [Full Text] [Related]  

  • 4. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z
    Rocz Akad Med Bialymst; 2004; 49():166-9. PubMed ID: 15631335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic Position and Incidence of Glomerular Diseases.
    Canney M; Induruwage D; Sahota A; McCrory C; Hladunewich MA; Gill J; Barbour SJ
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):367-374. PubMed ID: 32079609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence.
    Balafa O; Kalaitzidis R; Liapis G; Xiromeriti S; Zarzoulas F; Baltatzis G; Elisaf M
    Int Urol Nephrol; 2015 Aug; 47(8):1373-7. PubMed ID: 26092054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.
    Goto K; Imaizumi T; Hamada R; Ishikura K; Kosugi T; Narita I; Sugiyama H; Shimizu A; Yokoyama H; Sato H; Mauryama S
    J Nephrol; 2023 Nov; 36(8):2257-2267. PubMed ID: 37597092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with IgA nephropathy exhibit high systemic PDGF-DD levels.
    Boor P; Eitner F; Cohen CD; Lindenmeyer MT; ; Mertens PR; Ostendorf T; Floege J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2755-62. PubMed ID: 19357108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases.
    Tse WY; Howie AJ; Adu D; Savage CO; Richards NT; Wheeler DC; Michael J
    Nephrol Dial Transplant; 1997 May; 12(5):1017-27. PubMed ID: 9175062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Granulocyte Heparanase Activity in Neutrophils from Patients with Lupus Nephritis and Idiopathic Membranous Nephropathy.
    Szymczak M; Kuźniar J; Kopeć W; Żabińska M; Marchewka Z; Kościelska-Kasprzak K; Klinger M
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):83-91. PubMed ID: 27091112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA COVID-19 Vaccines and Their Risk to Induce a Relapse of Glomerular Diseases.
    Kronbichler A; Anders HJ
    J Am Soc Nephrol; 2022 Dec; 33(12):2128-2131. PubMed ID: 36332972
    [No Abstract]   [Full Text] [Related]  

  • 14. Glomerulonephritis Histopathological Pattern Change.
    AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
    BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
    Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
    BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complement in glomerulonephritis-are novel therapies ready for prime time?
    Cheung CK; Dormer JP; Barratt J
    Nephrol Dial Transplant; 2023 Jul; 38(8):1789-1797. PubMed ID: 36307926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome.
    Rijnink EC; Teng YK; Kraaij T; Wolterbeek R; Bruijn JA; Bajema IM
    Nephrol Dial Transplant; 2017 Apr; 32(4):654-662. PubMed ID: 28340077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
    Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
    Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis.
    Hogan SL; Satterly KK; Dooley MA; Nachman PH; Jennette JC; Falk RJ
    J Am Soc Nephrol; 2001 Jan; 12(1):134-142. PubMed ID: 11134259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmasking Renal Disease in Systemic Lupus Erythematosus: Beyond Lupus Nephritis.
    Nunez Cuello L; Perdomo W; Walgamage T; Walgamage M; Raut R
    Cureus; 2023 Aug; 15(8):e43091. PubMed ID: 37680420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.